160 related articles for article (PubMed ID: 22476400)
21. Imaging-guided core needle biopsy of papillary lesions of the breast.
Rosen EL; Bentley RC; Baker JA; Soo MS
AJR Am J Roentgenol; 2002 Nov; 179(5):1185-92. PubMed ID: 12388496
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic evaluation of papillary lesions of the breast on core biopsy.
Pathmanathan N; Albertini AF; Provan PJ; Milliken JS; Salisbury EL; Bilous AM; Byth K; Balleine RL
Mod Pathol; 2010 Jul; 23(7):1021-8. PubMed ID: 20473278
[TBL] [Abstract][Full Text] [Related]
23. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
[TBL] [Abstract][Full Text] [Related]
24. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.
Chen T; Sahin A; Aldaz CM
Cancer Res; 1996 Dec; 56(24):5605-9. PubMed ID: 8971163
[TBL] [Abstract][Full Text] [Related]
25. Papillary lesions of the breast diagnosed by core needle biopsy: 71 cases with surgical follow-up.
Bernik SF; Troob S; Ying BL; Simpson SA; Axelrod DM; Siegel B; Moncrief RM; Mills C; Aziz M
Am J Surg; 2009 Apr; 197(4):473-8. PubMed ID: 18723154
[TBL] [Abstract][Full Text] [Related]
26. Detection of allele loss on chromosome 16q in DNA isolated from fine needle aspiration specimens of breast tumors. A simulation study using surgically resected specimens.
Tsuda H; Sakamaki C; Shimamura K; Hirohashi S
Acta Cytol; 1996; 40(4):625-30. PubMed ID: 8693876
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens.
Shah VI; Flowers CI; Douglas-Jones AG; Dallimore NS; Rashid M
Histopathology; 2006 May; 48(6):683-91. PubMed ID: 16681684
[TBL] [Abstract][Full Text] [Related]
28. Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors.
Wen X; Cheng W
Ann Surg Oncol; 2013 Jan; 20(1):94-101. PubMed ID: 22878621
[TBL] [Abstract][Full Text] [Related]
29. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
[TBL] [Abstract][Full Text] [Related]
31. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.
Lakhani SR; Collins N; Stratton MR; Sloane JP
J Clin Pathol; 1995 Jul; 48(7):611-5. PubMed ID: 7560165
[TBL] [Abstract][Full Text] [Related]
32. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
Cleton-Jansen AM; van Eijk R; Lombaerts M; Schmidt MK; Van't Veer LJ; Philippo K; Zimmerman RM; Peterse JL; Smit VT; van Wezel T; Cornelisse CJ
BMC Cancer; 2008 Apr; 8():105. PubMed ID: 18416817
[TBL] [Abstract][Full Text] [Related]
33. Intracystic invasive papillary carcinoma of the male breast with analyses of loss of heterozygosity on chromosome 16q.
Yoshida M; Mouri Y; Yamamoto S; Yorozuya K; Fujii K; Nakano S; Fukutomi T; Hara K; Tsuda H
Breast Cancer; 2010 Apr; 17(2):146-50. PubMed ID: 19350359
[TBL] [Abstract][Full Text] [Related]
34. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
Cleton-Jansen AM; Buerger H; Haar Nt; Philippo K; van de Vijver MJ; Boecker W; Smit VT; Cornelisse CJ
Genes Chromosomes Cancer; 2004 Oct; 41(2):109-16. PubMed ID: 15287023
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide analysis of loss of heterozygosity in breast infiltrating ductal carcinoma distant normal tissue highlights arm specific enrichment and expansion across tumor stages.
Ruan X; Liu H; Boardman L; Kocher JP
PLoS One; 2014; 9(4):e95783. PubMed ID: 24748104
[TBL] [Abstract][Full Text] [Related]
36. [Management of non-malignant results in core needle biopsy of breast lesions].
Fan ZQ; Ouyang T; Li JF; Wang TF; Xie YT; Fan T; Zhang Z; Lin BY
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(34):2387-90. PubMed ID: 19087711
[TBL] [Abstract][Full Text] [Related]
37. Cell cycle marker expression in benign and malignant intraductal papillary lesions of the breast.
Loh SF; Cooper C; Selinger CI; Barnes EH; Chan C; Carmalt H; West R; Gluch L; Beith JM; Caldon CE; O'Toole S
J Clin Pathol; 2015 Mar; 68(3):187-91. PubMed ID: 25501285
[TBL] [Abstract][Full Text] [Related]
38. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers.
Dorion-Bonnet F; Mautalen S; Hostein I; Longy M
Genes Chromosomes Cancer; 1995 Nov; 14(3):171-81. PubMed ID: 8589033
[TBL] [Abstract][Full Text] [Related]
39. Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision?
Shamonki J; Chung A; Huynh KT; Sim MS; Kinnaird M; Giuliano A
Ann Surg Oncol; 2013 Dec; 20(13):4137-44. PubMed ID: 23943035
[TBL] [Abstract][Full Text] [Related]
40. Differential CD133 expression distinguishes malignant from benign papillary lesions of the breast.
Lin CH; Liu CH; Wen CH; Ko PL; Chai CY
Virchows Arch; 2015 Feb; 466(2):177-84. PubMed ID: 25433813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
